Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatment

Journal of General Virology

Volumn 84, Issue 5, 2003, Pages 1063-1070

  Luxton, Jenny C ^a   Nath, Rahul ^b   Derias, Nawal ^c   Herbert, Amanda ^c   Shepherd, Philip S ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING PROTEIN;

ARTICLE; CELL ACTIVITY; CELL SPECIFICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; IMMUNOGENICITY; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RECURRENT DISEASE; SQUAMOUS EPITHELIUM; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; WART VIRUS;

CAPSID PROTEINS; CELLS, CULTURED; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PEPTIDES; PROSPECTIVE STUDIES; RECURRENCE; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0037987842     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18931-0     Document Type: Article

References (14)

1. Altmann, A., Jochmus-Kudielka, I., Frank, R., Gausepohl, H., Moebius, U., Gissmann, L. & Meuer, S. C. (1992). Definition of immunogenic determinants of the human papillomavirus type-16 nucleoprotein-E7. Eur J Cancer 28A, 326-333.
2. De Gruijl, T. D., Bontkes, H. J. Walboomers, J. M. M. & 9 other authors (1996). Analysis of IgG reactivity against human papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study. Int J Cancer 68, 731-738.
3. De Gruljl, T. D., Bontkes, H. J. Walboomers, J. M. M. & 9 other authors (1998). Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. Cancer Res 58, 1700-1706.
4. De Gruijl, T. D., Bontkes, H. J. Walboomers, J. M. M. & 10 other authors (1999). Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia I: differential T-helper and IgG responses in relation to HPV infection and disease outcome. J Gen Viral 80, 399-408.
5. Gill, D. K., Bible, J. M., Biswas, C., Kell, B., Best, J. M., Punchard, N. A. & Cason, J. (1998). Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia. J Gen Virol 79, 1971-1976.
6. Kadish, A. S., Romney, S. L., Ledwidge, R., Tindle, R., Fernando, G. J. P., Zee, S. Y., Van Ranst, M. A. & Burk, R. D. (1994 . Cell-mediated immune responses to E7 peptides of human papilloma-virus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. J Gen Virol 75, 2277-2284.
7. Kadish, A. S., Ho, G. Y. F., Burk, R. D., Wang, Y. X., Romney, S. L., Ledwidge, R. & Angeletti, R. H. (1997). Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst 89, 1285-1293.
8. Luxton, J. C., Rowe, A. J., Cridland, J. C., Coletart, T., Wilson, P. & Shepherd, P. S. (1996). Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals. J Gen Virol 77, 1585-1593.
9. Luxton, J. C., Rose, R. C., Coletart, T., Wilson, P. & Shepherd, P. S. (1997). Serological responses to human papillomavirus type 16 L1 virus-like particles in women with cervical disease and in healthy controls. J Gen Virol 78, 917-923.
10. Nakagawa, M., Stites, D. P., Farhat, S., Judd, A., Moscicki, A. B., Canchola, A. J., Hilton, J. F. & Palefsky, J. M. (1996). T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia. Clin Diagn Lab Immunol 3, 205-210.
11. Shepherd, P., Rowe, A., Cridland, J., Chapman, M., Luxton, J. & Rayfield, L. (1994). An immunodominant region in HPV-16 L1 identified by T cell responses in patients with cervical dysplasias. In Immunology of Human Papillomaviruses (HPVs), pp. 233-241. Edited by M. Stanley. Cambridge: Cambridge University Press.
12. Shepherd, P. S., Rowe, A. J., Cridland, J. C., Coletart, T., Wilson, P. & Luxton, J. C. (1996). Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia. J Gen Virol 77, 593-602.
13. Strang, G., Hickling, J. K., Angus, G., McIndoe, J., Howland, K., Wilkinson, D., Ikeda, H. & Rothbard, J. B. (1990). Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol 71, 423-431.
14. Tsukui, T., Hildesheim, A. Schiffman, M. H. & 17 other authors (1996). Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res 56, 3967-3974.